Ally Bridge Group’s Cymabay Therapeutics CBAY Stock Holding History

Ally Bridge Group’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-489,938	Closed	-$11.6M	–	31
2023 Q4	$11.6M	Buy	+489,938	New	+$8.73M	6.9%	4

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ally Bridge Group's CBAY Position: Q1 2024 in Review

Ally Bridge Group sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 489,938 shares — an estimated $11.6M sold.

Ally Bridge Group first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $11.6M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Ally Bridge Group reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Ally Bridge Group sold 489,938 Cymabay Therapeutics shares in Q1 2024, an estimated $11.6M.
Ally Bridge Group first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Ally Bridge Group's Cymabay Therapeutics position peaked at $11.6M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Ally Bridge Group's 13F filing for Q1 2024, filed 15 May 2024.